Solara Active Pharma Sciences Ltd


Solara Active Pharma Sciences Ltd

Health CarePharmaceuticals and Biotechnology
  • Price (INR)406.40
  • Today's Change2.45 / 0.61%
  • Shares traded14.43k
  • 1 Year change-57.51%
  • Beta1.1301
Data delayed at least 15 minutes, as of Feb 02 2023 07:36 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Events & Activity

  • SOLARA:NSI price moved over +1.97% to 424.30
  • SOLARA:NSI trading volume exceeds daily average by +39.91%
  • SOLARA:NSI price rises above 15-day moving average to 424.30 at 12:32 GMT

Key statistics

As of last trade, Solara Active Pharma Sciences Ltd (SOLARA:NSI) traded at 406.40, 27.00% above the 52 week low of 320.00 set on Jun 20, 2022.
52-week range
320.00Jun 20 2022976.20Feb 09 2022
Previous close403.95
Average volume129.62k
Shares outstanding36.00m
Free float13.48m
P/E (TTM)--
Market cap14.54bn INR
EPS (TTM)-45.74
Annual div (ADY)--
Annual div yield (ADY)--
Div ex-dateAug 18 2021
Div pay-dateSep 24 2021
Data delayed at least 15 minutes, as of Feb 02 2023 07:36 GMT.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.